top of page

SPEAKER INFORMATION

Marianna Sabatino

AstraZeneca

Dr. Sabatino has over 17 years of research experience in multiple scientific disciplines, with 15 years in cell and gene therapy field. She has built and led Cell, Vector (Lentiand Retro) Process and Analytical Development teams and supported CMC strategy for early and late-stage lifecycle of multiple CAR-T and TCR-T assets including the commercial products, YESCARTA™ and TECARTUS™ while at Kite Pharma and products’ pipeline at Autolus Therapeutics and Arcellxwhere she served as Process Development Head. Earlier in her career, Dr. Sabatino was a Staff Scientist at the Cell Processing Section of the National Cancer Institute, Bethesda (MD), where she focused on the translation and development of multiple novel manufacturing platforms in support of diverse early Phase I/II programs for single and multi-center clinical trials in Oncology and Regenerative Medicine. Dr. Sabatino received her Medical Degree and professional training in Medical Oncology from the University of Siena Medical School, Siena, Italy.

bottom of page